Progress toward expanding smoking cessation options in the US and increasing the number of smokers who quit could come from changes in regulatory processes so innovations in nicotine replacement therapies have a better chance for success, advocates suggest.
A roadmap for potential changes in the Food and Drug Administration’s consideration of NRT proposals was provided in a recent...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?